Human B lymphocyte malignancies: exploitation of BLyS and APRIL and their receptors.

Current directions in autoimmunity

Volumn 8, Issue , 2005, Pages 266-288

  Jelinek, Diane F ^a   Darce, Jaime R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; BLYS RECEPTOR; MEMBRANE PROTEIN; TNFSF13 PROTEIN, HUMAN; TNFSF13B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

B CELL LEUKEMIA; B CELL LYMPHOMA; B LYMPHOCYTE; BIOLOGICAL MODEL; CELL DIFFERENTIATION; HUMAN; IMMUNOLOGY; MULTIPLE MYELOMA; PATHOLOGY; REVIEW;

B-CELL ACTIVATING FACTOR; B-LYMPHOCYTES; CELL DIFFERENTIATION; HUMANS; LEUKEMIA, B-CELL; LYMPHOMA, B-CELL; MEMBRANE PROTEINS; MODELS, IMMUNOLOGICAL; MULTIPLE MYELOMA; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13; TUMOR NECROSIS FACTOR-ALPHA;

EID: 16544363235     PISSN: 14222132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (89)